| Quarterly Financials | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 56 | 63 | 55 | 67 | 72 | 81 | 74 | 89 | 93 | 92 | 88 | 108 | 99 | 107 | 100 | 108 | 112 | 119 | 107 | 104 | 58 | 158 | 141 | 151 | 175 | 191 | 119 | 133 | 129 | 137 | 131 | 140 | 136 | 151 | 138 | 158 | 161 | 180 | 170 | 192 | 198 |
| Expenses | 37 | 36 | 35 | 41 | 42 | 64 | 51 | 60 | 53 | 53 | 49 | 60 | 56 | 61 | 61 | 71 | 64 | 64 | 62 | 77 | 48 | 91 | 89 | 95 | 94 | 87 | 81 | 93 | 92 | 103 | 100 | 111 | 100 | 111 | 103 | 121 | 115 | 129 | 124 | 130 | 135 |
| EBITDA | 20 | 26 | 20 | 27 | 30 | 17 | 23 | 30 | 39 | 39 | 39 | 48 | 43 | 46 | 39 | 37 | 48 | 55 | 45 | 26 | 9 | 67 | 52 | 55 | 81 | 104 | 38 | 40 | 37 | 33 | 31 | 29 | 36 | 40 | 35 | 37 | 46 | 51 | 46 | 62 | 63 |
| Operating Profit % | 34 % | 39 % | 36 % | 38 % | 39 % | 18 % | 28 % | 32 % | 39 % | 40 % | 42 % | 39 % | 42 % | 41 % | 37 % | 33 % | 42 % | 45 % | 41 % | 24 % | 15 % | 40 % | 36 % | 35 % | 43 % | 51 % | 31 % | 29 % | 28 % | 23 % | 22 % | 18 % | 26 % | 25 % | 23 % | 22 % | 27 % | 27 % | 25 % | 30 % | 30 % |
| Depreciation | 5 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 9 | 7 | 8 | 8 | 8 | 7 | 8 | 9 | 10 | 9 | 9 | 10 | 11 | 10 | 11 | 14 | 13 | 11 | 13 | 17 | 14 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 17 | 25 | 19 | 22 | 26 | 13 | 19 | 25 | 35 | 34 | 34 | 42 | 38 | 39 | 32 | 29 | 40 | 46 | 37 | 18 | 2 | 59 | 44 | 48 | 74 | 95 | 29 | 30 | 28 | 24 | 20 | 17 | 25 | 28 | 20 | 23 | 34 | 37 | 28 | 47 | 51 |
| Tax | 6 | 9 | 8 | 8 | 9 | 11 | 9 | 9 | 13 | 10 | 12 | 17 | 14 | 14 | 12 | 13 | 13 | 11 | 9 | 19 | 2 | 16 | 12 | 10 | 18 | 18 | 7 | 9 | 6 | 8 | 5 | 5 | 8 | 8 | 5 | 6 | 10 | 10 | 9 | 26 | 12 |
| Net Profit | 11 | 16 | 11 | 14 | 17 | 1 | 9 | 15 | 22 | 25 | 22 | 25 | 23 | 25 | 20 | 16 | 28 | 35 | 28 | -2 | 0 | 43 | 32 | 38 | 56 | 78 | 22 | 21 | 22 | 15 | 15 | 13 | 17 | 20 | 15 | 17 | 24 | 26 | 19 | 22 | 38 |
| EPS in ₹ | 2.33 | 3.28 | 2.13 | 2.71 | 3.18 | 0.22 | 1.71 | 2.90 | 4.10 | 4.59 | 4.03 | 4.68 | 4.35 | 4.70 | 3.81 | 3.09 | 5.20 | 6.73 | 5.21 | -0.30 | 0.04 | 8.15 | 6.13 | 7.14 | 10.51 | 14.70 | 4.05 | 4.04 | 4.11 | 3.80 | 2.78 | 2.36 | 3.26 | 3.84 | 2.78 | 3.54 | 4.52 | 4.99 | 3.58 | 4.17 | 7.35 |
Thyrocare Technologies
Thyrocare Technologies
1,212.50
-18.50
(-1.50%)
There are new updates from the company17 hours ago
View
Key Fundamentals
Market Cap
6,425.58 Cr
EPS
17.13
PE Ratio
61.32
Dividend Yield
1.71 %
Industry
Healthcare Services 52 Week High
1,435.00
52 Week Low
658.00
PB Ratio
13.27
Debt to Equity
0.06
Sector
Healthcare Service Provider Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Thyrocare Technologies Limited appointed Mr. Alok Kumar Jagnani (DIN: 00644360) as a Non-Executive and Non-Independent Director through a postal ballot and e-voting process. The ordinary resolution was passed with 99.9226% votes in favor and 0.0774% against, with a total of 4,57,32,435 valid votes cast. The remote e-voting period ran from August 28, 2025 to September 26, 2025. The scrutinizer's report confirmed the resolution was approved with the requisite majority. The company has a fully paid-up share capital of Rs. 52,99,44,470 divided into 5,29,94,447 equity shares of Rs. 10 each.
Thyrocare Technologies Limited disclosed that Docon Technologies Private Limited, its promoter and holding company, has pledged 3,23,23,232 equity shares representing 60.99% of the total share capital. The pledge was created in favor of Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of debenture holders to secure new debentures issued by API Holdings Ltd., the ultimate holding company. The pledge transaction was completed on September 17, 2025. Thyrocare's equity share capital remains at Rs. 52.99 crore comprising 5.29 crore equity shares of Rs. 10 face value each.
Vistra ITCL (India) Limited, acting as Debenture Trustee, released its pledge on 3,76,56,092 equity shares of Thyrocare Technologies Limited on September 16, 2025. The pledged shares represented 71.06% of Thyrocare's total voting capital. Following the pledge release, Vistra's encumbered shareholding in Thyrocare reduced to nil. Thyrocare has a total equity share capital of 5,29,94,447 shares with a face value of Rs. 10 each. The company's shares are listed on BSE Limited and National Stock Exchange of India Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,061.80 | #1 25,650.39 | 50.26 | #1 2,554.80 | 11.28 | #1 492 | 24.30 | 39.18 | |
1,987.00 | 10,294.14 | 68.63 | 1,346.30 | 10.64 | 146 | 18.90 | 44.92 | |
979.30 | 10,059.85 | 67.39 | 699.70 | 23.06 | 144 | 22.54 | 34.73 | |
1,212.50 | #4 6,425.58 | #7 61.32 | #5 702.20 | #4 20.80 | #4 91 | #2 60.25 | 52.05 | |
831.00 | 2,695.65 | 33.54 | 742.70 | 16.70 | 78 | 14.53 | 53.75 | |
294.50 | 1,533.78 | 46.28 | 255.90 | 15.11 | 31 | 19.48 | 39.14 | |
1,408.25 | 1,208.67 | 24.68 | 111.60 | 28.72 | 48 | 11.50 | 48.89 | |
310.20 | 986.76 | #1 10.91 | 1,170.80 | -18.47 | -134 | -35.12 | 56.44 | |
281.00 | 549.13 | 21.53 | 147.80 | #1 134.60 | 19 | #1 444.44 | 58.21 | |
184.95 | 128.86 | 85.44 | 41.80 | 13.28 | 2 | 0.00 | 40.66 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
20.80 %
Net Income Growth
30.65 %
Cash Flow Change
14.13 %
ROE
25.97 %
ROCE
43.70 %
EBITDA Margin (Avg.)
15.68 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 329 | 410 | 438 | 479 | 475 | 471 | 546 | 608 | 633 | 644 | 693 |
| Fixed Assets | 196 | 259 | 259 | 299 | 294 | 269 | 253 | 285 | 294 | 306 | 297 |
| Current Assets | 111 | 134 | 150 | 142 | 136 | 152 | 240 | 270 | 273 | 279 | 338 |
| Capital Work in Progress | 6 | 1 | 17 | 0 | 2 | 5 | 8 | 3 | 2 | 3 | 14 |
| Investments | 84 | 92 | 104 | 120 | 95 | 90 | 126 | 146 | 144 | 162 | 162 |
| Other Assets | 43 | 58 | 58 | 60 | 84 | 107 | 159 | 174 | 193 | 173 | 220 |
| Total Liabilities | 329 | 410 | 438 | 479 | 475 | 471 | 546 | 608 | 633 | 644 | 693 |
| Current Liabilities | 7 | 31 | 18 | 20 | 21 | 82 | 95 | 65 | 77 | 91 | 122 |
| Non Current Liabilities | 10 | 13 | 12 | 15 | 19 | 23 | 23 | 17 | 20 | 26 | 24 |
| Total Equity | 312 | 366 | 408 | 443 | 435 | 367 | 427 | 527 | 535 | 528 | 547 |
| Reserve & Surplus | 226 | 312 | 354 | 390 | 382 | 314 | 374 | 474 | 463 | 440 | 439 |
| Share Capital | 51 | 54 | 54 | 54 | 53 | 53 | 53 | 53 | 53 | 53 | 53 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -6 | 5 | -1 | -0 | -5 | 4 | 5 | 0 | 4 | -9 | 8 |
| Investing Activities | -18 | -18 | -42 | -43 | -12 | 1 | -49 | -24 | -39 | -91 | -53 |
| Operating Activities | 35 | 68 | 90 | 107 | 100 | 168 | 115 | 113 | 129 | 168 | 191 |
| Financing Activities | -23 | -45 | -49 | -64 | -94 | -165 | -62 | -89 | -86 | -85 | -130 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 66.14 % | 66.14 % | 71.22 % | 71.18 % | 71.18 % | 71.18 % | 71.14 % | 71.14 % | 71.14 % | 71.14 % | 71.14 % | 71.11 % | 71.11 % | 71.11 % | 71.11 % | 71.06 % | 71.06 % | 71.06 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.46 % | 0.00 % | 2.90 % | 2.49 % | 1.93 % | 2.77 % | 2.41 % | 3.23 % |
| DIIs | 7.14 % | 6.17 % | 6.07 % | 6.37 % | 6.52 % | 6.68 % | 8.66 % | 8.69 % | 8.45 % | 13.46 % | 13.33 % | 13.55 % | 14.88 % | 14.90 % | 14.80 % | 14.67 % | 14.97 % | 14.54 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.01 % | 6.32 % | 7.60 % | 7.44 % | 6.65 % | 6.71 % | 7.28 % | 8.07 % | 8.38 % | 9.42 % | 9.66 % | 9.15 % | 8.48 % | 8.66 % | 9.78 % | 9.16 % | 9.21 % | 8.94 % |
| Others | 21.71 % | 21.37 % | 15.11 % | 15.01 % | 15.66 % | 15.43 % | 12.91 % | 12.10 % | 12.03 % | 5.97 % | 2.42 % | 6.19 % | 2.63 % | 2.84 % | 2.38 % | 2.33 % | 2.36 % | 2.23 % |
| No of Share Holders | 0 | 44,722 | 53,140 | 62,936 | 65,769 | 66,315 | 66,431 | 71,412 | 74,386 | 76,292 | 72,000 | 68,844 | 64,823 | 61,636 | 59,377 | 56,666 | 57,403 | 54,566 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 10 | 20 | 5 | 25 | 15 | 18 | 18 | 21 |
| Dividend Yield (%) | 0.00 | 1.68 | 1.87 | 4.03 | 0.55 | 3.22 | 3.56 | 3.05 | 2.65 | 1.71 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Oct 2025 |  Quarterly Result Announcement | NA | 14 Oct 2025 | 1,179.30 | 1,231.00 |
| 19 Jun 2021 |  Dividend | ₹ 15.00 /share | 17 Jun 2021 | 1,059.45 | 1,287.65 |
| 12 May 2022 | Dividend | ₹ 15.00 /share | 11 May 2022 | 812.25 | 736.75 |
| 20 Apr 2023 | Dividend | ₹ 18.00 /share | 20 Apr 2023 | 446.85 | 504.70 |
| 16 Aug 2024 | Dividend | ₹ 18.00 /share | 16 Aug 2024 | 619.25 | 879.70 |
| 23 Aug 2024 |  Annual General Meeting | NA | 23 Aug 2024 | 818.05 | 892.80 |
| 23 Oct 2024 | Quarterly Result Announcement | NA | 23 Oct 2024 | 828.55 | 886.45 |
| 23 Jan 2025 | Quarterly Result Announcement | NA | 23 Jan 2025 | 827.90 | 806.35 |
| 23 Apr 2025 | Quarterly Result Announcement | NA | 23 Apr 2025 | 701.65 | 794.30 |
| 23 Jul 2025 | Quarterly Result Announcement | NA | 23 Jul 2025 | 1,164.70 | 1,186.65 |
| 25 Jul 2025 | Dividend | ₹ 21.00 /share | 25 Jul 2025 | 794.30 | 1,338.30 |
| 31 Jul 2025 | Annual General Meeting | NA | 31 Jul 2025 | 1,020.40 | 1,299.60 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
17 hours ago
17 hours agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoBoard Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 Declaration Of Interim Dividend And Proposal For Issue Of Bonus Shares.2 days ago
2 days ago Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotSep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.Sep 23, 2025
Sep 23, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 18, 2025
Sep 18, 2025Disclosure under Regulation 30A of LODRSep 15, 2025
Sep 15, 2025Disclosure under Regulation 30A of LODRSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Aug 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 25, 2025
Aug 25, 2025Thyrocare Technologies Limited Has Informed The Exchange About Intimation Regarding The Appointment Of Mr. Rahul Guha As Managing Director And Chief Executive Officer Of API Holdings Limited Ultimate Holding Company In Addition To His Current Position Of Aug 06, 2025
Aug 06, 2025Intimation Regarding The Appointment Of Mr. Rahul Guha Managing Director And Chief Executive Officer Of The Company As Managing Director And Chief Executive Officer Of API Holdings Limited Ultimate Holding CompanyAug 06, 2025
Aug 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 31, 2025
Jul 31, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 28, 2025
Jul 28, 2025General UpdateJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Jul 24, 2025Audio Recordings Of Earnings Conference Call For The Quarter Ended June 30 2025. Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Jul 23, 2025Financial Results For The Quarter Ended June 30 2025Jul 23, 2025
Jul 23, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On July 23 2025.Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2025
Jul 16, 2025Board Meeting Intimation for For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025Jul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 07, 2025
Jul 07, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 05, 2025
Jul 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 05, 2025
Jul 05, 2025Intimation Of Record Date For DividendJul 05, 2025
Jul 05, 2025Reg. 34 (1) Annual Report.Jul 05, 2025
Jul 05, 2025Notice Convening 25Th Annual General Meeting Of The Company.Jul 05, 2025
Jul 05, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-AcquisitionJun 03, 2025
Jun 03, 2025Mutual Fund Holdings
Nippon India Small Cap Fund Direct- Growth 
Quant Small Cap Fund Direct Plan-Growth 
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth 
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
Bandhan BSE Healthcare Index Fund Direct-Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
HDFC Pharma And Healthcare Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 52.05
ATR(14)
Less Volatile 52.63
STOCH(9,6)
Neutral 63.09
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 6.08
ADX(14)
Weak Trend 15.14
UO(9)
Bearish 51.16
ROC(12)
Uptrend And Accelerating 2.08
WillR(14)
Overbought -18.67
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
